How to hit the runs for fifty million travelers at risk.
Gorbach
Sherwood L
SL
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D019072:Antibiotic Prophylaxis; D003967:Diarrhea / Q000517:prevention & control*; D004927:Escherichia coli Infections / Q000517:prevention & control*; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D008800:Mexico; D012294:Rifamycins / Q000627:therapeutic use*; D000078262:Rifaximin; D014195:Travel; D014481:United States
D000900:Anti-Bacterial Agents; D005765:Gastrointestinal Agents; D012294:Rifamycins; D000078262:Rifaximin